Clin2
NCT06431308Possibly a fitRecruiting

Dietary help for weight-loss drug side effects

Obesity; Drug

Part of Hormones & metabolism clinical trials.

This study is testing whether a special diet can help reduce stomach side effects (like nausea or vomiting) from weight-loss medications such as Wegovy or Mounjaro. It is for people who are about to start or are taking these medications.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
120 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older
  • You have a BMI of 30 or more, or 27 or more with a weight-related condition like diabetes or high blood pressure
  • You can read and speak Hebrew
  • You are not pregnant, breastfeeding, or planning to become pregnant
  • You have not had bariatric surgery or a weight-loss procedure before

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06856928Not yet recruiting
How weight-loss medications affect appetite and hunger hormones

This study looks at how weight-loss medications affect appetite and the hormones that control hunger. It may help people who are starting or already taking these medications understand how they work and manage their weight better.

NCT07414043Recruiting
Understanding obesity drug treatments

This study aims to better understand patients who are prescribed medications like Orlistat, Mysimba, Saxenda, Wegovy, or Mounjaro for obesity. It will help doctors improve treatments for you.

Bologna, Bologna
NCT06174389Recruiting
Weight loss study: diet, appetite and body changes

This study looks at how diet, appetite, and body changes work together during weight loss. It's designed for people with a BMI of 30 to 50 who want to lose weight and are not taking certain medications or have certain health conditions.

Seattle, Washington
NCT07495904Recruiting
Weight loss drug effects on body muscle with extra protein

This trial tests a weight-loss medication (GLP-1 receptor agonist) combined with dietary protein to see if it helps protect muscle while losing fat. It is for adults with obesity who are not taking certain other medications or supplements.

Heraklion
NCT06645470Recruiting
Muscle and movement study for weight loss medications

This study looks at how anti-obesity medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) affect your muscles and movement. It may help researchers understand how to combine these drugs with exercise for better health.

Kansas City, Kansas
NCT07209046Not yet recruiting
Probiotic support after stopping weight-loss medication

This trial tests whether a daily probiotic supplement can help people maintain their weight after they stop taking a GLP-1 medication (like Ozempic or Wegovy). It aims to see if the probiotic helps keep the weight off.

Hear when a new Obesity; Drug trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.